Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rosenbaum

Showing results (371-380 of 471) with videos related to

Pageof 48
Sort By:
RMD Open|May 7, 2020
The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEWIrene van der Horst-Bruinsma, Rianne van Bentum, Frank D Verbraak, et al.
ACR Open Rheumatology|May 1, 2020
Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 StudiesAtul A Deodhar, Corine Miceli-Richard, Xenofon Baraliakos, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 26, 2021
American College of Rheumatology White Paper on Antimalarial Cardiac ToxicityJulianna Desmarais, James T Rosenbaum, Karen H Costenbader, et al.
Investigative Ophthalmology & Visual Science|January 31, 2003
Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndromeRalph D Levinson, Min S Park, Sarah M Rikkers, et al.
Ophthalmology|June 24, 2014
Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trialEric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2021
American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal ToxicityJames T Rosenbaum, Karen H Costenbader, Julianna Desmarais, et al.
JAMA Ophthalmology|March 22, 2014
Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trialEric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
Seminars in Arthritis and Rheumatism|July 15, 2019
New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A reviewJames T Rosenbaum, Bahram Bodaghi, Cristobal Couto, et al.
Eye (London, England)|March 29, 2025
Electroretinography of disease activity and treatment response in birdshot chorioretinopathyChristopher R Rosenberg, Elizabeth White, Aseel Alsamarraie, et al.
Annals of the Rheumatic Diseases|April 24, 2012
Mycobacterial diseases and antitumour necrosis factor therapy in USAK L Winthrop, R Baxter, L Liu, et al.
Pageof 48

Showing results (371-380 of 471) with videos related to

Sort By:
Pageof 48
RMD Open|May 7, 2020
The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEWIrene van der Horst-Bruinsma, Rianne van Bentum, Frank D Verbraak, et al.
ACR Open Rheumatology|May 1, 2020
Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 StudiesAtul A Deodhar, Corine Miceli-Richard, Xenofon Baraliakos, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 26, 2021
American College of Rheumatology White Paper on Antimalarial Cardiac ToxicityJulianna Desmarais, James T Rosenbaum, Karen H Costenbader, et al.
Investigative Ophthalmology & Visual Science|January 31, 2003
Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndromeRalph D Levinson, Min S Park, Sarah M Rikkers, et al.
Ophthalmology|June 24, 2014
Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trialEric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2021
American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal ToxicityJames T Rosenbaum, Karen H Costenbader, Julianna Desmarais, et al.
JAMA Ophthalmology|March 22, 2014
Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trialEric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
Seminars in Arthritis and Rheumatism|July 15, 2019
New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A reviewJames T Rosenbaum, Bahram Bodaghi, Cristobal Couto, et al.
Eye (London, England)|March 29, 2025
Electroretinography of disease activity and treatment response in birdshot chorioretinopathyChristopher R Rosenberg, Elizabeth White, Aseel Alsamarraie, et al.
Annals of the Rheumatic Diseases|April 24, 2012
Mycobacterial diseases and antitumour necrosis factor therapy in USAK L Winthrop, R Baxter, L Liu, et al.
Pageof 48